India probes mystery illness after 17 die: Reports
Authorities in India-administered Jammu and Kashmir were investigating a mysterious disease that has claimed the lives of 17 people, local media reports said Saturday.
Jan 25, 2025
0
136
MeSH tree: C25.723.705
Authorities in India-administered Jammu and Kashmir were investigating a mysterious disease that has claimed the lives of 17 people, local media reports said Saturday.
Jan 25, 2025
0
136
A controversial new study out Monday in a US medical journal could reignite debate over fluoride's safety in water, linking higher exposure levels to lower IQ in children.
Jan 6, 2025
3
125
Dry January is a somewhat recent trend in which some people stop drinking alcohol for the month of January. In general, cutting back on alcohol consumption is a good idea for our health, especially after the holidays from ...
Jan 3, 2025
0
17
In rare and severe cases of alcohol withdrawal, one NHS trust is prescribing alcohol to treat patients. A specialized team at Sandwell and West Birmingham Hospitals NHS Trust prescribes carefully controlled doses of alcohol ...
Dec 17, 2024
1
12
For the first time, researchers have used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient's response to CAR T cell therapy in real time. The organoid's response ...
Dec 9, 2024
0
45
Lead exposure is a risk to any human, but children are most vulnerable to the element's neurotoxicity, which can lead to developmental delays, learning difficulties and mood changes among other symptoms. There has been some ...
Oct 29, 2024
0
11
Chemicals are omnipresent today. They enter our bodies through food, air or the skin. But how do these complex mixtures of chemicals affect our health? In a new study, a research team from the Helmholtz Centre for Environmental ...
Oct 17, 2024
0
129
The U.S. Environmental Protection Agency on Tuesday finalized a rule that will require the removal of all lead pipes from the country's water systems.
Oct 8, 2024
0
21
In the first study to report real-world outcomes from ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor (CAR)-T therapy for multiple myeloma, patients experienced efficacy and safety results similar to those ...
Oct 4, 2024
0
38
In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, patients with relapsed or refractory large B-cell lymphoma (LBCL) responded ...
Sep 30, 2024
0
38